MergerJul 14, 2026, 04:57 PM
Beacon Topco Prepares for Merger with Barinthus Bio, Clywedog
AI Summary
Beacon Topco, Inc. filed its 10-Q, reporting no operational activity, assets, or liabilities for the period ended June 30, 2026, as it was formed solely for a business combination. The company is preparing for a merger with Barinthus Biotherapeutics plc and Clywedog Therapeutics, Inc., which was unanimously approved by both boards. Upon closing, Beacon Topco will be renamed "Clywedog Therapeutics Holdings, Inc." and its shares will be listed on Nasdaq under "CLYD".
Key Highlights
- Formed September 24, 2025, as a subsidiary of Barinthus Biotherapeutics plc.
- Entered Merger Agreement with Barinthus Bio and Clywedog on September 29, 2025.
- Barinthus Bio shareholders to own ~34%, Clywedog stockholders ~66% post-merger.
- SEC declared S-4 Registration Statement effective on April 22, 2026.
- Company to be renamed "Clywedog Therapeutics Holdings, Inc." and listed as "CLYD".
- Reported $0 in assets, liabilities, revenues, and net income for Q2 2026.
Price Impact
More from CLYD